Source: ERS Lung Science Conference 2021



Rating:

Share or cite this content

Citations should be made in the following way:
Chris Kyriakopoulos, Greece. PP308 – Endothelial injury in Chronic Obstructive Pulmonary Disease assessed by microalbuminuria (MAB) and von Willebrand factor levels and activity. ERS Lung Science Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: Vascular endothelial growth factor (VEGF) as marker of pulmonary hypertension in children with asthma Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Endothelial dysfunction in Chronic Obstructive Pulmonary Disease patients according to exposure by tobacco or biomass Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019 Response of plasma von Willebrand factor to systemic endothelial injury in pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 545s Year: 2006 Could Monocyte /HDL cholesterol ratio predict cardiovascular events in patients with Chronic Obstructive Pulmonary Disease ? Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Association between estimated Glomerular Filtration Rate (eGFR) and cardiovascular risk in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Microalbuminuria and von Willebrand factor antigen (vWF) as markers of endothelial dysfunction in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 123s Year: 2004 Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD) Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Obstructive Sleep Apnoea is a Pulmonary Embolism severity risk factor. Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea Year: 2017 Endothelial injury in COPD assessed by microalbuminuria (MAB) and von Willebrand factor levels (vWf:Ag) and activity (vWf:Ac) Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD). Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease Year: 2020 Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Respiratory, cardiovascular and systemic factors associated with brain damage in Chronic Obstructive Pulmonary Disease (COPD) and/or coronary artery disease (CAD) Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco as risk factor to cachexia. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 LATE-BREAKING ABSTRACT: Evaluation of Angiopoietin-2 and Thrombomodulin as Biomarkers for Pulmonary Hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Translational studies of lung disease Year: 2017